PCSK9 and metabolic syndrome: PCSK9 has emerging therapeutic roles in dyslipidemia-associated diseases, particularly atherosclerosis, and new evidence shows that LVs play a key role in controlling cholesterol efflux from peripheral tissues, such as the atherosclerotic lesion24.